Management of Newly Elevated Liver Function Tests in Sepsis
Immediate Assessment
- For a patient with newly elevated liver function tests after 2 days of normal LFTs in sepsis, a comprehensive evaluation for potential causes should be performed while continuing sepsis management, as abnormal LFTs are more commonly attributable to secondary effects of sepsis rather than primary liver disease 1
- Evaluate for treatment-related GI and hepatic adverse effects, as many medications used in sepsis management can cause liver enzyme elevations 1
- Review all current medications, particularly those with known hepatotoxicity potential (antimicrobials, statins, acetaminophen) 1, 2
- Obtain fractionated bilirubin tests to determine if the hyperbilirubinemia is conjugated or unconjugated 3
- Monitor LFTs throughout hospitalization, especially in patients receiving potentially hepatotoxic medications 1
Potential Causes of Newly Elevated LFTs in Sepsis
- Secondary effects of sepsis, including systemic inflammatory response syndrome, cytokine storm, ischemic hepatitis/shock, and drug hepatotoxicity, can cause newly elevated LFTs 1
- Antimicrobial agents are common culprits in drug-induced liver injury during sepsis management 1
Management Approach
- Investigate non-sepsis causes of liver disease in all patients with abnormal LFTs 1
- Consider hepatitis serology (HBsAg, anti-HBc IgM, anti-HAV IgM) to rule out viral causes 4, 2
- Perform abdominal ultrasound to exclude biliary obstruction, verify vessel permeability, and rule out chronic liver disease 4, 3
Monitoring Recommendations
- For mild elevations (<5× upper limit of normal), monitor liver enzymes weekly until normalization 2
- For moderate elevations (5-10× ULN), monitor liver enzymes every 2-3 days until stable or improving 2
- For severe elevations (>10× ULN), consider more aggressive monitoring and potential medication adjustments 2